Serum lipid level | Cerebral infarction patients (n = 920) | Controls (n = 1015) | ||||||
---|---|---|---|---|---|---|---|---|
ɛ2(n = 65) | ɛ3(n = 684) | ɛ4(n = 171) | P values | ɛ2(n = 140) | ɛ3(n = 763) | ɛ4(n = 112) | P values | |
TG, mmol/L | 2.064 ± 1.986 | 1.787 ± 1.434 | 1.773 ± 1.285 | 0.324 | 2.449 ± 2.917* | 2.069 ± 2.208 | 2.310 ± 2.879 | 0.170 |
TC, mmol/L | 4.893 ± 1.245 | 5.048 ± 1.272 | 5.093 ± 1.320 | 0.560 | 5.170 ± 1.476 | 5.096 ± 1.351 | 5.242 ± 1.558 | 0.534 |
HDL-C, mmol/L | 1.302 ± 0.336 | 1.277 ± 0.326 | 1.234 ± 0.336 | 0.225 | 1.281 ± 0.393 | 1.284 ± 0.367 | 1.256 ± 0.407 | 0.762 |
LDL-C, mmol/L | 2.584 ± 0.766*◇ | 2.925 ± 0.894 | 3.031 ± 0.922 | 0.003 | 2.734 ± 0.971*◇ | 2.866 ± 0.917◇ | 3.061 ± 1.064 | 0.023 |
Apo-A1, g/L | 1.179 ± 0.327 | 1.150 ± 0.284◇ | 1.098 ± 0.307* | 0.064 | 1.174 ± 0.315 | 1.161 ± 0.344 | 1.082 ± 0.282 | 0.050 |
Apo-B, g/L | 0.802 ± 0.222*◇ | 0.905 ± 0.263 | 0.934 ± 0.276 | 0.002 | 0.858 ± 0.312*◇ | 0.904 ± 0.286◇ | 0.955 ± 0.347 | 0.035 |
Apo-A1/ Apo-B | 1.605 ± 0.739*◇ | 1.366 ± 0.501◇ | 1.244 ± 0.409* | < 0.001 | 1.529 ± 0.643*◇ | 1.401 ± 0.616◇ | 1.260 ± 0.506* | 0.002 |